Literature DB >> 31377854

Subtotal parathyroidectomy versus total parathyroidectomy with autotransplantation for secondary hyperparathyroidism: an updated systematic review and meta-analysis.

Qianqian Yuan1, Yiqin Liao1, Rui Zhou1, Jiuyang Liu1, Jianing Tang1, Gaosong Wu2.   

Abstract

PURPOSE: The optimal surgical approach of parathyroidectomy for patients with secondary hyperparathyroidism (SHPT) has been controversial. The updated meta-analysis aimed to compare the effectiveness of subtotal parathyroidectomy (SPTX) versus total parathyroidectomy with autotransplantation (TPTX + AT).
METHODS: A thorough systematic search was performed on the databases of PubMed, EMBASE, and Cochrane library to identify eligible studies. Data were extracted and pooled into a meta-analysis. The primary outcomes were the symptomatic improvement, radiological changes, hypocalcemia rate, the requirement for vitamin D analogues, time to recurrence, recurrence, persistence, and reoperation rates of SPTX versus TPTX + AT.
RESULTS: A total of 18 studies with 3656 patients (1864 patients in SPTX and 1792 patients in TPTX + AT group) were included, and 15 studies were included in quantitative synthesis. No significant difference was observed in symptomatic improvement (93.3%, 89.0%; P = 0.99), radiological changes (85.4%, 85.3%; P = 0.91), hypocalcemia rate (16.6%, 18.1%; P = 0.29), persistence rate (6.1%, 2.0%; P = 0.16), time to recurrence (mean difference 1.46; P = 0.87), recurrence rate (9.2%, 7.1%; P = 0.76), and reoperation rate (5.3%, 5.8%; P = 0.66) between SPTX and TPTX + AT groups. Longer operative time (150 vs. 120 min), prolonged in-hospital stay (5.0 vs. 4.1 days), lower 1-month serum calcium level, and higher requirement for vitamin D analogues at 12 months were significantly observed in patients who underwent TPTX + AT compared to SPTX.
CONCLUSIONS: The two surgical approaches were both effective at controlling SHPT in clinical and laboratory terms. However, most of the data shown were not statistically significant. It was acceptable that surgeons chose either SPTX or TPTX + AT for SHPT.

Entities:  

Keywords:  End-stage renal disease; Meta-analysis; Parathyroidectomy; Secondary hyperparathyroidism

Mesh:

Year:  2019        PMID: 31377854     DOI: 10.1007/s00423-019-01809-7

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  38 in total

1.  Quality of life after surgery in secondary hyperparathyroidism, comparing subtotal parathyroidectomy with total parathyroidectomy with immediate parathyroid autograft: Prospective randomized trial.

Authors:  Wellington Alves Filho; Willemijn Y van der Plas; Marilia D G Brescia; Climerio P Nascimento; Patricia T Goldenstein; Ledo M Massoni Neto; Sergio S Arap; Melani R Custodio; Rodrigo O Bueno; Rosa M A Moyses; Vanda Jorgetti; Schelto Kruijf; Fabio L M Montenegro
Journal:  Surgery       Date:  2018-08-03       Impact factor: 3.982

2.  Results of reoperations for persistent or recurrent secondary hyperparathyroidism in hemodialysis patients.

Authors:  J F Henry; A Denizot; J Audiffret; G France
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

3.  Parathormone levels after subtotal and total (autotransplantation) parathyroidectomy for secondary hyperparathyroidism.

Authors:  G A Sicard; C B Anderson; K A Hruska; K J Martin; E E Etheredge
Journal:  J Surg Res       Date:  1980-12       Impact factor: 2.192

4.  Recurrent hyperparathyroidism and forearm parathyromatosis after total parathyroidectomy.

Authors:  Adrienne L Melck; Sally E Carty; Raja R Seethala; Michaele J Armstrong; Michael T Stang; Jennifer B Ogilvie; Linwah Yip
Journal:  Surgery       Date:  2010-08-25       Impact factor: 3.982

5.  Parathyroidectomy in chronic renal failure.

Authors:  M Koonsman; K Hughes; R Dickerman; K Brinker; E Dunn
Journal:  Am J Surg       Date:  1994-12       Impact factor: 2.565

6.  Results of surgical treatment of renal hyperparathyroidism.

Authors:  E Neonakis; M H Wheeler; H Krishnan; G A Coles; F Davies; J S Woodhead
Journal:  Arch Surg       Date:  1995-06

7.  Parathyroid surgery in chronic renal failure: subtotal parathyroidectomy or autotransplantation?

Authors:  C L Welsh; G W Taylor; W R Cattell; L R Baker
Journal:  Br J Surg       Date:  1984-08       Impact factor: 6.939

8.  Subtotal parathyroidectomy versus total parathyroidectomy with autotransplant in secondary hyperparathyroidism — a single-centre prospective cohort of 43 patients.

Authors:  Radu Mircea Neagoe; Mircea Mureșan; Septimiu Voidăzan; Ionela Pașcanu; Cristina Pop Radu; Daniela Tatiana Sala
Journal:  Endokrynol Pol       Date:  2016       Impact factor: 1.582

9.  Evidence-based recommendations for blinding in surgical trials.

Authors:  Pascal Probst; Steffen Zaschke; Patrick Heger; Julian C Harnoss; Felix J Hüttner; André L Mihaljevic; Phillip Knebel; Markus K Diener
Journal:  Langenbecks Arch Surg       Date:  2019-03-01       Impact factor: 3.445

Review 10.  Impact of surgical parathyroidectomy on chronic kidney disease-mineral and bone disorder (CKD-MBD) - A systematic review and meta-analysis.

Authors:  Mugurel Apetrii; David Goldsmith; Ionut Nistor; Dimitrie Siriopol; Luminita Voroneanu; Dragos Scripcariu; Marc Vervloet; Adrian Covic
Journal:  PLoS One       Date:  2017-11-06       Impact factor: 3.240

View more
  3 in total

1.  Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK).

Authors:  T Weber; C Dotzenrath; H Dralle; B Niederle; P Riss; K Holzer; J Kußmann; A Trupka; T Negele; R Kaderli; E Karakas; F Weber; N Rayes; A Zielke; M Hermann; C Wicke; R Ladurner; C Vorländer; J Waldmann; O Heizmann; S Wächter; S Schopf; W Timmermann; D K Bartsch; R Schmidmaier; M Luster; K W Schmid; M Ketteler; C Dierks; P Schabram; T Steinmüller; K Lorenz
Journal:  Langenbecks Arch Surg       Date:  2021-04-21       Impact factor: 3.445

2.  A predictive risk score to diagnose hypocalcemia after parathyroidectomy in patients with secondary hyperparathyroidism: a 22-year retrospective cohort study.

Authors:  Mattabhorn Phimphilai; Suchada Inya; Worapaka Manosroi
Journal:  Sci Rep       Date:  2022-06-09       Impact factor: 4.996

3.  Therapeutic efficacy of two surgical methods on the secondary hyperparathyroidism.

Authors:  Chao Gu; Zhenyu Ye; Yanan Wang; Qin Wang; Jie Qi; Jianhua Chen; Shan Chen; Zekuan Xu
Journal:  Gland Surg       Date:  2020-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.